FORT LAUDERDALE, Fla. – In spite of years of research, treatments for Alzheimer’s disease have not been promising, until recently.
Dr. Hazel Wiley with the Memory Disorder Center at Broward Health North said a small clinical trial showed a reduction in amyloid plaques in the brain, a key component of Alzheimer’s disease.
Wiley underscored that many other drugs have tried, and failed, to achieve the same result and that this current Phase 2 trial was very small.
The study still needs to move on Phase 3 human trials in order to be considered for approval by the Food & Drug Administration, which could take at least 2 years.
Data on the benefit of CBD oil continues to expand, concluding now evidence that it could be helpful in treating a variety of skin conditions.